Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: I. aztreonam and carbapenems

Carbapenem stewardship – positive impact on hospital ecology

(2012) Ana Lucia Lei Munhoz Lima et al.   Brazilian Journal of Infectious Diseases

Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence

(2011) David P. Nicolau et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

A survey of the utilization of anti-pseudomonal beta-lactam therapy in cystic fibrosis patients

(2011) Jeffery T. Zobell et al.   PEDIATRIC PULMONOLOGY

Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary Exacerbation

(2010) Don B. Sanders et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Effect of Azithromycin on Pulmonary Function in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosaA Randomized Controlled Trial

(2010) Lisa Saiman   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

High dose intermittent ticarcillin–clavulanate administration in pediatric cystic fibrosis patients

(2010) Jeffery T. Zobell et al.   Journal of Cystic Fibrosis

Return of FEV1after pulmonary exacerbation in children with cystic fibrosis

(2010) Don B. Sanders et al.   PEDIATRIC PULMONOLOGY

Cystic Fibrosis Pulmonary Guidelines

(2009) Patrick A. Flume et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Continuous versus Intermittent Infusions of Ceftazidime for Treating Exacerbation of Cystic Fibrosis

(2009) D. Hubert et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis

(2009) George Z. Retsch-Bogart et al.   CHEST

Pharmacokinetics, Safety, and Tolerability of Doripenem After 0.5-, 1-, and 4-Hour Infusions in Healthy Volunteers

(2009) Iolanda Cirillo et al.   JOURNAL OF CLINICAL PHARMACOLOGY

A survey of once-daily dosage tobramycin therapy in patients with cystic fibrosis

(2009) Daniel J. Van Meter et al.   PEDIATRIC PULMONOLOGY

Pulmonary Complications of Cystic Fibrosis

(2009) Patrick A Flume   Respiratory Care

Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis

(2007) Philipp Latzin et al.   Journal of Cystic Fibrosis